NDC 55289-736-15 - SKELAXIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55289-736
- Requested NDC
- 55289-736-15
- Package NDCs from labels
- 55289-736-10, 55289-736-20, 55289-736-21, 55289-736-30, 55289-736-40, 55289-736-15
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Effective date
- 2022-05-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SKELAXIN ® (Metaxalone) Tablets | PD-Rx Pharmaceuticals, Inc. | 2022-05-11 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55289-736-10 | EA - Each | 55289-736 | 743913e9-15eb-4911-b515-cc6166f7b8f3 | 1 | 2013-02-13 |
| 55289-736-15 | EA - Each | 55289-736 | 64c1cde6-a385-4a0f-b31d-30ff077854bd | 1 | 2013-02-13 |
| 55289-736-20 | EA - Each | 55289-736 | 2fd96553-2c44-4360-a497-aad934db63a9 | 1 | 2013-02-13 |
| 55289-736-21 | EA - Each | 55289-736 | 78b86e17-6594-43c8-8fff-e22f986a14a6 | 1 | 2013-02-13 |
| 55289-736-30 | EA - Each | 55289-736 | cb700729-2c9c-4aa9-99e6-da9afec9375e | 1 | 2013-02-13 |
| 55289-736-40 | EA - Each | 55289-736 | ef00f0a0-9381-43da-8c86-02cf171bac2c | 1 | 2013-03-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| METAXALONE | ACTIVE INGREDIENT | 1NMA9J598Y | SKELAXIN (METAXALONE) TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| METAXALONE | ACTIVE MOIETY | 1NMA9J598Y | SKELAXIN (METAXALONE) TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| ALGINIC ACID | INACTIVE INGREDIENT | 8C3Z4148WZ | SKELAXIN (METAXALONE) TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| CALCIUM | INACTIVE INGREDIENT | SY7Q814VUP | SKELAXIN (METAXALONE) TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | SKELAXIN (METAXALONE) TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | SKELAXIN (METAXALONE) TABLET [PD-RX PHARMACEUTICALS, INC.] | 6 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metaxalone | METAXALONE | Northwind Health Company, LLC | d9cefc55-7643-ce9b-e053-2a95a90aff12 | 2026-01-01 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Northwind Health Company, LLC | f2b46d69-1c20-5ae9-e053-2a95a90a60a9 | 2026-01-01 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | A-S Medication Solutions | d4caa7c6-afb5-43a2-ba38-cf30106b1d62 | 2025-12-05 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | AvPAK | 9b21a974-6a5a-9efb-e9de-470363217126 | 2025-11-26 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | PHOENIX RX LLC | 3a7c8b4d-7add-cb31-e063-6294a90a37f8 | 2025-10-21 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | PHOENIX RX LLC | 413b300d-4163-afef-e063-6394a90a618f | 2025-10-15 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Actavis Pharma, Inc. | b3a4f6bc-abd4-4b8e-970f-59b3aa6f17a0 | 2025-07-30 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | BluePoint Laboratories | c91c0fb0-0b61-4e45-8bea-d0bf57ca7068 | 2025-07-07 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Advanced Rx of Tennessee, LLC | 36c1d263-48ce-831b-e063-6394a90a0a2b | 2025-05-29 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Amneal Pharmaceuticals LLC | 3aa9dba9-29b0-4520-a0f7-66d19d52c6bc | 2025-03-28 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Major Pharmaceuticals | 8c1e10fe-0330-4bf8-a94d-aeed80f6aef1 | 2025-03-03 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | PD-Rx Pharmaceuticals, Inc. | edc6ba8d-2d45-4833-8dc7-e2d4e5d72856 | 2025-02-04 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Dr. Reddys Laboratories Limited | 02eb5938-cd59-4a81-853d-a4148d813a94 | 2025-01-20 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Advanced Rx of Tennessee, LLC | b3279496-293e-7e1f-e053-2a95a90ab506 | 2024-12-31 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Advanced Rx Pharmacy of Tennessee, LLC | bd1c9022-aadc-af1f-e053-2995a90a0b42 | 2024-12-31 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Advanced Rx Pharmacy of Tennessee, LLC | b713a0f2-d47a-0ae7-e053-2995a90a5b85 | 2024-12-31 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Quality Care Products, LLC | f05bb280-6736-4215-be5b-0e5f7991cd87 | 2024-12-17 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Bryant Ranch Prepack | a12304b7-6477-4518-8db5-898879c62caf | 2024-11-13 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Bryant Ranch Prepack | c2dd7071-cba3-410c-ade5-9d7e5af42038 | 2024-09-16 | Warnings, Adverse reactions | 1NMA9J598Y |
| Metaxalone | METAXALONE | Amneal Pharmaceuticals of New York LLC | de3448df-4ca1-44ec-bad1-486549cddf64 | 2024-08-30 | Warnings, Adverse reactions | 1NMA9J598Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.